Clinical and pathological implications of GSTM1 and GSTT1 gene deletions in sporadic breast cancer
AbstractThere is a lack of consensus about the influence of GST M1/T1 gene deletions (DEL) on sporadic breast cancer (SBC). To evaluate the occurrence of DEL in 177 SBC cases and in 169 controls, and compare clinical and biological characteristics. A lower frequency of GSTM1 DEL was observed in mulatto women, OR=0.48 (0.24–0.98). The risk of nuclear grade 3 tumors (GN3) was lower in patients with GSTT1 DEL, OR=0.37 (0.15–0.90). DEL of at least one gene (ALOG) was associated with women who had not breastfed, OR=0.41 (0.19–0.88), and with negative hormone receptor, HR–, ORadj=2.25 (1.03–4.90). Both genes deleted (BGD) was associated with non-classic invasive ductal carcinoma (NCDC), ORadj=12.09 (1.03–142.03). Mulatto women with SBC had a lower frequency of GSTM1 DEL, while tumors differentiated were related to GSTT1 DEL. HRtumors were related with DEL ALOG, and the BGD was associated with a greater risk of NCDC.
- Abstract views: 1512
- FULL TEXT: 260
Copyright (c) 2011 Cassio Cardoso Filho, Gustavo Lourenço, Julia Yoriko Shinzato, Luiz Carlos Zeferino, Fernando Ferreira Costa, Carmen Silvia Passos Lima, Maria Salete Costa Gurgel
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.